BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26589540)

  • 21. Update on the management of alcoholic steatohepatitis.
    Stickel F; Seitz HK
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):189-97. PubMed ID: 23799218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticosteroids or non-corticosteroids: a fresh perspective on alcoholic hepatitis treatment.
    Wang F; Wang BY
    Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):458-64. PubMed ID: 21947718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis.
    Duan F; Liu C; Chang C; Song S; Zhai H; Cheng J; Yang S
    Am J Drug Alcohol Abuse; 2024 Mar; 50(2):191-206. PubMed ID: 38011683
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic and therapeutic strategies for severe alcoholic hepatitis].
    Kim W
    Korean J Gastroenterol; 2015 Jan; 65(1):4-11. PubMed ID: 25603848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of long-term outcome in severe alcoholic hepatitis.
    Potts JR; Goubet S; Heneghan MA; Verma S
    Aliment Pharmacol Ther; 2013 Sep; 38(6):584-95. PubMed ID: 23879720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcoholic hepatitis: current challenges and future directions.
    Singal AK; Kamath PS; Gores GJ; Shah VH
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):555-64; quiz e31-2. PubMed ID: 23811249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal management of alcoholic hepatitis.
    Raff E; Singal AK
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):25-38. PubMed ID: 24632766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes.
    Mathurin P
    Liver Transpl; 2005 Nov; (11 Suppl 2):S21-4. PubMed ID: 16237730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.
    Mathurin P; Mendenhall CL; Carithers RL; Ramond MJ; Maddrey WC; Garstide P; Rueff B; Naveau S; Chaput JC; Poynard T
    J Hepatol; 2002 Apr; 36(4):480-7. PubMed ID: 11943418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial.
    De BK; Gangopadhyay S; Dutta D; Baksi SD; Pani A; Ghosh P
    World J Gastroenterol; 2009 Apr; 15(13):1613-9. PubMed ID: 19340904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials.
    Imperiale TF; McCullough AJ
    Ann Intern Med; 1990 Aug; 113(4):299-307. PubMed ID: 2142869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcoholic hepatitis: Prognosis and treatment.
    Casanova J; Bataller R
    Gastroenterol Hepatol; 2014 Apr; 37(4):262-8. PubMed ID: 24656653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: recent insights into clinical decision-making in severe alcoholic hepatitis.
    Dunne PDJ; Forrest EH
    Aliment Pharmacol Ther; 2017 Aug; 46(3):274-281. PubMed ID: 28543549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of compromised urea synthesis in patients with alcoholic hepatitis.
    Glavind E; Aagaard NK; Gronbaek H; Orntoft NW; Vilstrup H; Thomsen KL
    Scand J Gastroenterol; 2018 May; 53(5):592-597. PubMed ID: 29113530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
    Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
    J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis.
    Philips CA; Phadke N; Ganesan K; Ranade S; Augustine P
    Indian J Gastroenterol; 2018 May; 37(3):215-225. PubMed ID: 29931479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroids or cocktails for alcoholic hepatitis.
    O'Shea R; McCullough AJ
    J Hepatol; 2006 Apr; 44(4):633-6. PubMed ID: 16503078
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical inquiries. How does pentoxifylline affect survival of patients with alcoholic hepatitis?
    Ghavami P; Neher JO; St Anna L
    J Fam Pract; 2008 Dec; 57(12):822-3. PubMed ID: 19080768
    [No Abstract]   [Full Text] [Related]  

  • 40. Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial.
    Sidhu SS; Goyal O; Singla M; Bhatia KL; Chhina RS; Sood A
    J Assoc Physicians India; 2012 May; 60():20-2. PubMed ID: 23029716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.